Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cutting scans, keeping safety: a new streamlined approach to liver cancer treatment

NCT ID NCT07043387

NEW Recruiting now Disease control Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This trial tests a streamlined version of radioembolization, a treatment that delivers tiny radioactive beads directly to liver tumors. The standard procedure requires extra imaging beforehand to check for radiation leakage to the lungs, which can delay treatment. For patients with small tumors (7 cm or less) and no signs of vein invasion, this risk is very low, so the trial skips that extra scan. The goal is to see if this faster, same-day procedure still works well and is safe, measuring tumor response and tracking side effects over a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radioactive microspheres (SIR-Spheres) delivered via radioembolization
What this could lead to
If successful, this streamlined approach could make liver cancer treatment faster and more efficient, reducing delays without compromising safety.
What could go wrong
The trial is small and observational, so results may not apply broadly. There is a small risk of radiation reaching the lungs, though the study aims to minimize it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholangiocarcinoma colorectal carcinoma colorectal neoplasm Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOLANGIOCARCINOMA METASTATIC COLORECTAL CARCINOMA (MCRC) METASTATIC LIVER CANCER

Contacts and locations

Locations

  • National Cancer Center

    NOT_YET_RECRUITING

    Goyang-si, South Korea

  • Samsung Medical Center

    NOT_YET_RECRUITING

    Seoul, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, South Korea

  • Severance hospital

    NOT_YET_RECRUITING

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.